Products
16530 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly Mini Future with ISIN code: CH1467039538 | Eli Lilly | Mini Future | Short | 700 | 639.334 | 0.67 | 0.010 | 0.68 | 100 | -1.47% | ― | ― | 11 Aug. 2025 | |
Eli Lilly Constant Leverage with ISIN code: CH1290993323 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 0.039 | 0.001 | 0.04 | 1 | -2.50% | -87.00% | -92.35% | 11 Mar. 2024 | |
Eli Lilly Constant Leverage with ISIN code: CH1187773655 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 10.18 | ― | ― | 1 | 0.00% | -57.35% | -68.95% | 19 May. 2022 | |
Eli Lilly Constant Leverage with ISIN code: CH1276586992 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 0.096 | ― | ― | 1 | 0.00% | -89.09% | -93.73% | 17 Aug. 2023 | |
Eli Lilly Constant Leverage with ISIN code: CH1346000313 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 0.48 | 0.010 | 0.49 | 1 | -2.04% | -56.36% | -68.21% | 9 Jul. 2024 | |
Eli Lilly Constant Leverage with ISIN code: CH1276586984 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 2 | ― | ― | 1 | 0.00% | -57.26% | -68.85% | 17 Aug. 2023 | |
Eli Lilly Constant Leverage with ISIN code: CH1346000321 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 0.009 | ― | ― | 1 | 0.00% | -30.77% | -47.06% | 9 Jul. 2024 | |
Eli Lilly Constant Leverage with ISIN code: CH1199369716 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 0.53 | ― | ― | 1 | 0.00% | -89.48% | -93.99% | 24 Jun. 2022 | |
Eli Lilly Constant Leverage with ISIN code: CH1235292922 | Eli Lilly | Constant Leverage | Long | ― | 639.334 | 0.021 | ― | ― | 1 | 0.00% | -78.13% | -90.45% | 29 Nov. 2022 | |
Eli Lilly Constant Leverage with ISIN code: CH1346000297 | Eli Lilly | Constant Leverage | Short | ― | 639.334 | 0.86 | 0.010 | 0.87 | 1 | -1.15% | 79.17% | 109.76% | 9 Jul. 2024 | |
Eli Lilly Constant Leverage with ISIN code: CH1346000305 | Eli Lilly | Constant Leverage | Short | ― | 639.334 | 6.34 | 0.050 | 6.39 | 1 | -0.78% | 55.77% | 81.66% | 9 Jul. 2024 | |
Eli Lilly Constant Leverage with ISIN code: CH1423415715 | Eli Lilly | Constant Leverage | Short | ― | 639.334 | 9.48 | 0.160 | 9.64 | 1 | -1.66% | 107.89% | 137.00% | 7 May. 2025 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1326190878 | Eli Lilly | Knock-Out Warrant (open end) | Call | 613.546 | 639.334 | 0.25 | 0.010 | 0.26 | 100 | -3.85% | -77.48% | -83.33% | 2 Feb. 2024 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1326190860 | Eli Lilly | Knock-Out Warrant (open end) | Call | 567.64 | 639.334 | 0.6 | 0.010 | 0.61 | 100 | -1.64% | -59.46% | -67.74% | 2 Feb. 2024 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1467040080 | Eli Lilly | Knock-Out Warrant (open end) | Call | 500.118 | 639.334 | 1.14 | 0.010 | 1.15 | 100 | -0.87% | ― | ― | 11 Aug. 2025 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1377900159 | Eli Lilly | Knock-Out Warrant (open end) | Put | 1,195.565 | 639.334 | 4.5 | 0.010 | 4.51 | 100 | -0.22% | 22.95% | 38.89% | 4 Sep. 2024 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1359210445 | Eli Lilly | Knock-Out Warrant (open end) | Put | 1,096.287 | 639.334 | 3.7 | 0.010 | 3.71 | 100 | -0.27% | 29.82% | 51.02% | 17 Jun. 2024 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1366462252 | Eli Lilly | Knock-Out Warrant (open end) | Put | 1,045.498 | 639.334 | 3.29 | 0.010 | 3.3 | 100 | -0.30% | 34.84% | 60.49% | 16 Jul. 2024 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1362338449 | Eli Lilly | Knock-Out Warrant (open end) | Put | 995.795 | 639.334 | 2.89 | 0.010 | 2.9 | 100 | -0.34% | 41.67% | 75.15% | 1 Jul. 2024 | |
Eli Lilly Knock-Out Warrant (open end) with ISIN code: CH1377907931 | Eli Lilly | Knock-Out Warrant (open end) | Put | 945.261 | 639.334 | 2.49 | 0.010 | 2.5 | 100 | -0.40% | 51.83% | 99.20% | 19 Sep. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.